Terns Pharmaceuticals Inc (TERN)
7.099
+0.16
(+2.29%)
USD |
NASDAQ |
Nov 04, 16:00
7.055
-0.04
(-0.62%)
After-Hours: 20:00
Terns Pharmaceuticals Total Assets (Quarterly): 230.88M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 230.88M |
| March 31, 2024 | 246.77M |
| December 31, 2023 | 268.52M |
| September 30, 2023 | 271.69M |
| June 30, 2023 | 289.70M |
| March 31, 2023 | 301.28M |
| December 31, 2022 | 287.03M |
| September 30, 2022 | 192.59M |
| June 30, 2022 | 144.86M |
| Date | Value |
|---|---|
| March 31, 2022 | 156.67M |
| December 31, 2021 | 168.07M |
| September 30, 2021 | 179.89M |
| June 30, 2021 | 188.01M |
| March 31, 2021 | 199.24M |
| December 31, 2020 | 92.29M |
| September 30, 2020 | 17.41M |
| December 31, 2019 | 23.90M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
17.41M
Minimum
Sep 2020
301.28M
Maximum
Mar 2023
191.69M
Average
192.59M
Median
Sep 2022
Total Assets (Quarterly) Benchmarks
| Eli Lilly and Co | 75.61B |
| Viking Therapeutics Inc | 937.89M |
| Biomarin Pharmaceutical Inc | 6.851B |
| Elite Pharmaceuticals Inc | 87.85M |
| Verrica Pharmaceuticals Inc | 52.01M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 12.20M |
| Shareholders Equity (Quarterly) | 218.68M |